Axon Guidance Molecules and Optic Nerve Disease
Axon Guidance Molecules and Optic Nerve Disease
批准号:
7497727
负责人:
DAVID W SRETAVAN
金额:
$4.15万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2008-07-31
关键词:
AdultAffectAgeAge-MonthsAnimalsApoptosisAxonAxonal TransportBehaviorBindingBiologicalBiological AssayBlindnessCalciumCell DeathCellsCessation of lifeChronicDBA/2 MouseDataDepthDevelopmentDiseaseElevationEmbryoEventExhibitsExposure toFamilyFoundationsFunctional disorderFutureGeneral PopulationGenesGlaucomaGrowth ConesHealthIn Situ HybridizationInbred DBA MiceLeadLinkLocalizedMechanicsMediatingMolecularMouse StrainsMusNatural regenerationNervous System PartNervous system structureNeuronal InjuryNeuronsOptic DiskOptic NerveOptic Nerve InjuriesPathogenesisPathologyPatientsPhysiologic Intraocular PressurePhysiologicalPhysiologyPlayPrimatesPropertyReportingResearchRetinaRetinal Ganglion CellsRisk FactorsRoleSeveritiesSignal PathwaySignal TransductionSiteTestingTherapeuticThinkingTimeTissuesVisualWitWorkaxon growthaxon guidancedisabilityinterestneurodevelopmentneuronal cell bodynonhuman primateoptic nerve disorderreceptorreceptor bindingresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The chronic and progressive loss of Retinal Ganglion Cells (RGC) and their axons is a hallmark of
Glaucoma. Despite its well-appreciated link with elevated intraocular pressure (IOP), the sequence of
molecular events that lead to RGC dysfunction and subsequent death is not clearly understood. Although
increases in IOP may directly impact RGC cell bodies in the retina, a substantial body of evidence suggests
that the site of primary damage may in fact be at the optic nerve head (ONH). It is thought that intrinsic
tissue properties in the ONH makes it especially susceptible to mechanical damage, resulting in localized
cellular and molecular changes that affect optic nerve axon physiology and survival. The identification of
the direct molecular triggers of optic nerve axon dysfunction in glaucoma will significantly enhance our
understanding of disease pathogenesis and may also potentially provide new important therapeutic avenues.
Axon guidance molecules serve as key developmentalproteins that collectively exert major effects on
RGC axons during formation of the optic nerve. Axon guidance molecules can directly activate intracellular
signaling pathways in developing RGC axons to trigger cytoskeletal disassembly and the elimination of
inappropriate axon branches. Recent work has reported that axon guidance molecules are also present in the
adult nervous system particularly in settings of neuronal injury and pathology, where they may have
previously unappreciated injurious functions on both neurons and axons. In our own work, we have found
that specific guidance molecules reappear after optic nerve trauma and govern the ability of damaged adult
RGC axons to regenerate. A possible functional role for axon guidance molecules in causing axon damage in
more chronic and progressive forms of optic nerve injury, such as glaucoma, has not been explored.
In this application, we propose a set of studies to test the notion that axon guidance molecule
expression is up-regulated at the glaucomatous adult ONH region and that these axon guidance molecules are
capable of eliciting significant physiological responses in adult RGC axons. These studies form the initial
tests of a broader hypothesis that axon guidance molecules at the ONH trigger RGC axon dysfunction and are
involved in the development or severity of glaucomatous damage. Our preliminary evidence shows that
expression of specific axon guidance molecules are indeed up-regulated at the ONH of DBA/2J glaucomatous
mice around the time of onset of axon damage. Furthermore, these molecules are capable of physiologically
activating adult RGC axons, consistent with our specific hypothesis that guidance molecules may have a
primary role in mediating axon damage in glaucoma.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
-
批准号:7503958
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2008
-
负责人:DAVID W SRETAVAN
-
依托单位:
Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
-
批准号:8094388
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2008
-
负责人:DAVID W SRETAVAN
-
依托单位:
Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
-
批准号:7885773
-
项目类别:
-
资助金额:$2.59万
-
财政年份:2008
-
负责人:DAVID W SRETAVAN
-
依托单位:
Microscale Axon Repair As A Novel Paradigm For Nerve Injuries
-
批准号:7647954
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2008
-
负责人:DAVID W SRETAVAN
-
依托单位:
Axon Guidance Molecules and Optic Nerve Disease
-
批准号:6955762
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2005
-
负责人:DAVID W SRETAVAN
-
依托单位:
Axon Guidance Molecules and Optic Nerve Disease
-
批准号:7100154
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2005
-
负责人:DAVID W SRETAVAN
-
依托单位:
Axon Guidance Molecules and Optic Nerve Disease
-
批准号:7271197
-
项目类别:
-
资助金额:$14.71万
-
财政年份:2005
-
负责人:DAVID W SRETAVAN
-
依托单位:
CORE--MOLECULAR BIOLOGY SUPPORT MODULE
-
批准号:6713451
-
项目类别:
-
资助金额:$20.8万
-
财政年份:2003
-
负责人:DAVID W SRETAVAN
-
依托单位:
Imaging Analysis and Graphics Core
-
批准号:10665567
-
项目类别:
-
资助金额:$9.35万
-
财政年份:1997
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF RETINAL GANGLION CELL AXON PATHWAYS
-
批准号:6247842
-
项目类别:
-
资助金额:$2.28万
-
财政年份:1997
-
负责人:DAVID W SRETAVAN
-
依托单位:
Imaging Analysis and Graphics Core
-
批准号:10426212
-
项目类别:
-
资助金额:$9.35万
-
财政年份:1997
-
负责人:DAVID W SRETAVAN
-
依托单位:
Imaging Analysis and Graphics Core
-
批准号:10203971
-
项目类别:
-
资助金额:$9.35万
-
财政年份:1997
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF CENTRAL RETINAL PATHWAYS
-
批准号:6179239
-
项目类别:
-
资助金额:$29.08万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF CENTRAL RETINAL PATHWAYS
-
批准号:2444369
-
项目类别:
-
资助金额:$23.16万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
Guidance Molecules in Retinal Axon Disease
-
批准号:7525813
-
项目类别:
-
资助金额:$36.36万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF CENTRAL RETINAL PATHWAYS
-
批准号:2711119
-
项目类别:
-
资助金额:$24.17万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF CENTRAL RETINAL PATHWAYS
-
批准号:2164728
-
项目类别:
-
资助金额:$22.27万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF CENTRAL RETINAL PATHWAYS
-
批准号:2907370
-
项目类别:
-
资助金额:$26.74万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
MOLECULAR DEVELOPMENT OF CENTRAL RETINAL PATHWAYS
-
批准号:2164726
-
项目类别:
-
资助金额:$25.15万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
Guidance Molecules in Retinal Axon Regeneration
-
批准号:6908883
-
项目类别:
-
资助金额:$37.88万
-
财政年份:1994
-
负责人:DAVID W SRETAVAN
-
依托单位:
海外基金